These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1221378)

  • 1. Serum lipoprotein abnormalities in ischaemic heart disease.
    Lewis B; Carlson LA; Mancini M; Micheli H
    Postgrad Med J; 1975; 51(8):37-9. PubMed ID: 1221378
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum triglyceride and lipoprotein cholesterol in male survivor of ischaemic heart disease in eastern Uttar Pradesh (north India).
    Kabi BC; Somani PN; Koteswara Rao GR
    Indian Heart J; 1985; 37(3):176-8. PubMed ID: 4065916
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma lipids and lipoprotein cholesterol in patients with premature ischaemic heart disease and ischaemic cerebrovascular disease.
    Das S; Tripathy BB; Bidyadhar S; Das JP; Rath S; Swain AK; Das DK
    J Assoc Physicians India; 1984 Nov; 32(11):949-54. PubMed ID: 6526783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum lipids, lipoproteins and coronary disease].
    Nikkilä EA
    Duodecim; 1972; 88(21):1271-82. PubMed ID: 4656210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels.
    Lewis B; Chait A; Wootton ID; Oakley CM; Krikler DM; Sigurdsson G; February A; Maurer B; Birkhead J
    Lancet; 1974 Feb; 1(7849):141-6. PubMed ID: 4129717
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary hyperlipoproteinemias in patients with coronary disease and peripheral arterial circulatory disorders].
    Klemens UH; Kissling E; von Löwis of Menar P; Schröder R; Bremer A
    Verh Dtsch Ges Inn Med; 1972; 78():1342-6. PubMed ID: 4665541
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pindolol on serum lipoproteins in patients with coronary heart disease.
    Karmakoski J; Viikari J; Rönnemaa T
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):189-91. PubMed ID: 6862723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor predictability of lipoprotein cholesterol from whole serum lipids.
    Jones RJ; Cohen L; Dobrilovic L
    J Atheroscler Res; 1968; 8(3):463-70. PubMed ID: 5660507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between platelet aggregation and hyperlipemia. Clinical study].
    Cafiero M; Buono G; Pacileo S; Pirone S; Sensale P
    Boll Soc Ital Cardiol; 1977; 22(7):1042-7. PubMed ID: 618240
    [No Abstract]   [Full Text] [Related]  

  • 13. The genetic contribution to coronary heart disease through lipoprotein concentrations.
    Slack J
    Postgrad Med J; 1975; 51(8):27-32. PubMed ID: 1221377
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of serum lipids, lipoproteins, lipid peroxide products and metals with coronary heart disease.
    Wen Y; Qian XX; Jia GL; Gao SB; Jin YF; Han DY; He SF
    Chin Med J (Engl); 1993 Mar; 106(3):167-70. PubMed ID: 8325139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma lipid and lipoprotein content in chronic ischemic heart disease depending on patients' personality trends].
    Bel'chenko DI; Lazarev VI
    Ter Arkh; 1982; 54(10):55-7. PubMed ID: 7179121
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Serum lipoprotein abnormalities in ischaemic heart disease and peripheral vascular disease.
    Lewis B; Sigurdsson G; Chait A; Oakley C; Birkhead J; Maurer B
    Clin Sci Mol Med; 1974 Feb; 46(2):12P. PubMed ID: 4817252
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
    Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein fractions and antithrombin III consumption during clotting.
    Winter JH; Bennett B; McTaggart F; Douglas AS
    Thromb Haemost; 1982 Jun; 47(3):236-8. PubMed ID: 7112497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.